Restinil en es it fr

Restinil Brand names, Restinil Analogs

Restinil Brand Names Mixture

  • No information avaliable

Restinil Chemical_Formula


Restinil RX_link

No information avaliable

Restinil fda sheet

Restinil msds (material safety sheet)

Restinil Synthesis Reference

No information avaliable

Restinil Molecular Weight

309.469 g/mol

Restinil Melting Point

< 25 oC

Restinil H2O Solubility

Soluble as HCl salt

Restinil State


Restinil LogP


Restinil Dosage Forms

Tablets (oral, 1 mg)

Restinil Indication

Used for the symptomatic treatment of parkinsonism.

Restinil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Restinil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Restinil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Restinil Patient Information

Restinil Organisms Affected

Humans and other mammals